CD274 and breast cancer: Recently, a meta-analysis including initial 4184 entries, 38 retrospective studies of breast cancer revealed that the overall pooled PD-L1 protein positivity rate was 24% (95% CI 15–64%) in tumor cells and 33% (95% CI 14–56%) in immune cells [37].